Abbott hosts conference call for fourth-quarter earnings
ABTABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m....
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
ABT(NYSE:ABT) Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic stenosis (a common and life-threatening heart valve disease) who are at low or intermediate surgical risk CE Mark is based on safety and effectiveness data from...
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
ABTAll 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning school earning $1 million from Abbott for student or community health Abbott is releasing...
Peering Into Abbott Laboratories's Recent Short Interest
ABTGoldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
ABTGoldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.
FDA Approves Abbott's Tendyne Transcatheter Mitral Valve Replacement System To Treat People With Mitral Valve Disease
ABTAbbott Laboratories Announces REFLECT Real-World Studies Results That Shows Use Of FreeStyle Libre Continuous Glucose Monitoring Technology Associated With Significant Reduction In Risk Of Hospitalization For Heart Complications In People With Diabetes.
ABTJensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know
ABTThe Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and climate resilience.
Abbott Enters First-Of-Its-Kind Agreement To Integrate Data From Libre CGM Systems Directly Into Epic's Electronic Health Record Systems In US
ABTA Look Into Abbott Laboratories Inc's Price Over Earnings
ABTReported Saturday, Abbott Presents New Volt PFA System Data Highlighting Outstanding Long-Term Safety And Freedom From Arrhythmia At 12 Months
ABTReported Sunday, Abbott's AVEIR CSP Study Demonstrates First Successful Leadless Conduction System Pacing In Left Bundle Branch Area
ABT10 Health Care Stocks Whale Activity In Today's Session
ABTRaymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $142
ABTPiper Sandler Reiterates Overweight on Abbott Laboratories, Raises Price Target to $145
ABTRBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $145
ABTWells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $147
ABTMorgan Stanley Maintains Equal-Weight on Abbott Laboratories, Raises Price Target to $127
ABTThese Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
ABTBarclays Maintains Overweight on Abbott Laboratories, Raises Price Target to $159
ABTDemystifying Abbott Laboratories: Insights From 11 Analyst Reviews
ABTStifel Maintains Buy on Abbott Laboratories, Raises Price Target to $145
ABTJefferies Maintains Hold on Abbott Laboratories, Raises Price Target to $137
ABTUS Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'
ABTU.S. stock futures rose on Thursday ahead of the long weekend, with Good Friday falling on April 18 and Easter Sunday on April 20.
Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zone
ABTStocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaq
ABTPowell says tariffs could lead to higher inflation and slower growth, but Fed won't intervene in market losses. Stocks tumble, gold prices rise.
Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?
ABTU.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China.
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
ABTAbbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty
ABTAbbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth.
Abbott Reaffirms 2025 Adjusted EPS Of $5.05-$5.25 And Consensus Of $5.15, With Organic Sales Growth Of 7.5%-8.5% And Adjusted Operating Margin Of 23.5%-24.0%
ABTAbbott Expects Q2 2025 Adjusted EPS Of $1.23 to $1.27 Versus Consensus Of $1.25
ABTAbbott Laboratories Q1 2025 Adj EPS $1.09 Beats $1.07 Estimate, Sales $10.36B Miss $10.40B Estimate
ABTUS Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert
ABTU.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket.
Dow Falls Over 150 Points Even As Citi, Bank Of America Earnings Beat Expectations: Greed Index Remains In 'Extreme Fear' Zone
ABTAbbott Laboratories, Travelers Companies And 3 Stocks To Watch Heading Into Wednesday
ABTThis House of Representative Just Bought Up To $390K In Abbott Laboratories Stock
ABTAbbott Laboratories's Earnings Outlook
ABTHow To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings
ABTAbbott Laboratories offers a quarterly dividend amount of 59 cents per share ($2.36 a year). Here's how investors can pocket $500 monthly.
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $32K Worth of Abbott Laboratories Stock
ABTAbbott Laboratories Highlights Late-Breaking Data Of TriClip For People With Leaky Tricuspid Heart Valve
ABTAbbott Laboratories Announces That The FDA Has Approved An Investigational Device Exemption For Its Coronary Intravascular Lithotrips System To Evaluate The Treatment Of Severe Calcification In Coronary Arteries Prior To Stenting
ABTWhat Does the Market Think About Abbott Laboratories?
ABTDecoding Abbott Laboratories's Options Activity: What's the Big Picture?
ABTB of A Securities Maintains Buy on Abbott Laboratories, Raises Price Target to $150
ABTAbbott Laboratories Options Trading: A Deep Dive into Market Sentiment
ABTRecent Report Shows That Sen. Shelley M Capito Sold Up to $75K Worth of Comcast Stock
ABTFlorida Rep. Jared Moskowitz Sold Up to $15K Worth of West Pharmaceutical Servs Stock
ABTAbbott Laboratories Options Trading: A Deep Dive into Market Sentiment
ABTWhere Abbott Laboratories Stands With Analysts
ABTCitigroup Maintains Buy on Abbott Laboratories, Raises Price Target to $160
ABT